Aristolochic Acid Nephropathy: What We Know and What We Have to Do
XM Li,HY Wang
DOI: https://doi.org/10.1111/j.1440-1797.2004.00252.x
2004-01-01
Nephrology
Abstract:NephrologyVolume 9, Issue 3 p. 109-111 Aristolochic acid nephropathy: What we know and what we have to do XIAOMEI LI, Corresponding Author XIAOMEI LI Renal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaDr Xiao Li, Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Email: [email protected]Search for more papers by this authorHAIYAN WANG, HAIYAN WANG Renal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaSearch for more papers by this author XIAOMEI LI, Corresponding Author XIAOMEI LI Renal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaDr Xiao Li, Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Email: [email protected]Search for more papers by this authorHAIYAN WANG, HAIYAN WANG Renal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaSearch for more papers by this author First published: 04 June 2004 https://doi.org/10.1111/j.1440-1797.2004.00252.xCitations: 27Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Wang H, Wang M, Cui T. Biological nephrotoxins. In: BA Molitoris and WF Finn (eds). Acute Renal Failure. Philadelphia: WB Saunders Co., 2001: 383–9. 2 Vanherwegham JL, Depierreux M, Tielemans C et al. Rapidly progressive interstitial fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–91. 3 Vanhaelen M, Vanhaelen-Fastre R, But P et al. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343: 174. 4 Vanherwegham JL. Misuse of herbal remedies: The case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J. Altern. Complement Med. 1998; 4: 9–13. 5 Cosyns JP. Aristolochic acid and ‘Chinese herbs nephropathy’: A review of the evidence to date. Drug 2003; 26: 33–48. 6 Committee of The Pharmacology Encyclopaedia of Chinese Public Health Ministry. The Pharmacology Encyclopaedia. Beijing: Beijing Chemical Publications, 2000 : 31–185. 7 Wu SH. Two cases of acute renal failure caused by Mutong. Jiang Xi Zhong Yi 1964; 10: 12–14 (In Chinese). 8 Hong YS, Huang YL, Wang YJ. Over-dose of Mutong causes renal failure and death. Zhe Jiang Zhong Yi Za Zhi 1965; 8: 32 (In Chinese). 9 Zhou FJ, Lu HW, Nie CF. Toxicity of Mutong causes acute renal failure. Chin. J. Nephrol. 1988; 4: 223–4 (In Chinese). 10 Yin G, Hu W, Li L. Renal injury of Mutong toxicity. J. Nephrol. Dial. Transplant. (Shenzangbing Yu Toxi Shenyizhi Za Zhi) 1999; 8: 10–14 (In Chinese). 11 Li X, Yang L, YuY et al. An analysis of the clinical and pathological characteristics of Mu-Tong (a Chinese herb) induced tubulointerstitial nephropathy. Chin. J. Intern. Med. (Zhonghua Nei Ke Za Zhi) 2001; 40: 681–7. 12 Chen W, Chen Y, Li A et al. The clinical and pathological manifestations of aristolochic acid nephropathy: report of 58 cases. Natl Med. J. China. (Zhonghua Yi Xue Za Zhi) 2001; 81: 1101–5. 13 Yu Y, Zheng F, Li H. Chinese herbs-induced renal failure with Fanconi's syndrome. Chin. J. Intern. Med. (Zhonghua Nei Ke Za Zhi) 2003; 42: 110–12. 14 Hu W, Liu Z, Chen Z et al. Clinical and pathological features in patients with renal injury associated with Aristolochia manshuriensis Kom. J. Nephrol. Dial. Transplant. (Shenzangbing Yu Toxi Shenyizhi Za Zhi) 2003; 12: 504–11. 15 Tanaka A, Nishida R, Yokoi H et al. The characteristic pattern of aminoaciduria in patients with aristolochic acid–induced Fanconi's syndrome: Could aminoaciduria by the hallmark of this syndrome? Clin. Nephrol. 2000; 54: 198–202. 16 Lee S, Lee T, Lee B et al. Faconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology 2004; 9: 126–9. 17 Krumme B, Endeir R, Vanhaelen M et al. Reversible Fanconi's syndrome after ingestion of a Chinese herbal ‘remedy’ containing aristolochic acid. Nephrol. Dial. Transplant. 2001; 16: 400–2. 18 Martinez MM, Nortier J, Vereerstraeten P et al. Progression rate of Chinese herb nephropathy: Impact of Aristolochia fangchi ingested dose. Nephrol. Dial. Transplant. 2002; 17: 408–12. 19 Su T, Li X. Progression of chronic tubulointerstitial nephritis induced by chinese herb containing aristolochic acid: Follow up of fourty patients. J. Am. Soc. Nephrol. 2003; 14: A300 (abstract F-P01076). 20 Chen W, Chen Y, Li A. Uroepithelial carcinoma in patients with chronic aristolochic acid nephropathy. Chin. J. Nephrol. (Zhonghua Shenzangbing Za Zhi) 2004; 20: 15–17. 21 Mengs U, Stotzem CD. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch. Toxicol. 1993; 67: 307–11. 22 Cosyns JP, Dehoux JP, Guiot Y et al. Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy? Kidney Int. 2001; 59: 2164–73. 23 Cronin AJ, Maidment G, Cook T et al. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol. Dial. Transplant. 2002; 17: 524–5. 24 Stiborova M, Fernando RC, Schimeiser HH et al. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-post-labelling analysis using different chromatographic procedures. Carcinogenesis 1994; 15: 1187–92. 25 Bieler CA, Stiborova M, Wiessler M et al. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 1997; 18: 1063–7. 26 Li H, Liu Z, Chen H et al. Ultrastructural changes of human proximal tubular epithelial cells incubated with aristolochic acid I. J. Nephrol. Dial. Transplant. (Shenzangbing Yu Toxi Shenyizhi Za Zhi) 2001; 10: 242–6. 27 Li B, Li X, Zhang C et al. Injury in renal proximal tubular epithelial cells induced by aristololactam I. China J. Chinese Materia Medica. (Zhongguo Zhongyao Za Zhi) 2004; 29: 78–83. 28 Li B, Li X, Zhang C et al. Cellular mechanism of renal proximal tubular epithelial cell injury induced by aristolochic acid I and aristololactam I. J. Peking University Health Sci. (Beijing Daxue Xuebao Yixue Ban) 2004; 36: 36–40. 29 Gao R, Zheng F, Liu Y et al. Aristolochic acid I-induced apoptosis in LLCPK1 cells. Chin J. Nephrol. (Zhonhua Shenzangbing Za Zhi) 1999; 15: 162–5. 30 Wen X, Zheng F, Gao R et al. Transdifferentiation of cultured human tubular epithelial cells induced by aristolochic acid I. J. Nephrol. Dial. Transplant. (Shenzangbing Yu Toxi Shenyizhi Za Zhi) 2000; 9: 206–9. 31 Yang L, Li X, Wang H. A comparative study of Manchurian dutchmanspipe and antibiotics induced acute tubular necrosis in renal cellular biological features. Chinese J. Intern. Trad. West. Med. (Zhongguo Zhong Xi Yi Jiehe Za Zhi) 2003; 23: 329–34. 32 Chen W, Chen Y, Zhang J et al. Study on transdifferentiation of renal tubular epithelial cells in patients with chronic aristolochic acid nephropathy. Chinese J. Nephrol. (Zhonhua Shenzangbing Za Zhi) 2003; 19: 6–9. 33 Yang L, Li X, Wang H. Roles of connective tissue growth factor in the fibrosis of Manchurian dutchmanspipe induced tubulointerstial nephropathy. Chinese J. Nephrol. (Zhonhua Shenzangbing Za Zhi) 2003; 19: 213–18. Citing Literature Volume9, Issue3June 2004Pages 109-111 ReferencesRelatedInformation